Both, AZD5153 and I-BET151 as single agents efficiently reduced proliferation and metabolic activity at low dosage in all tested BL and DLBCL cell lines, with slightly lower IC50 values for AZD compared to I-BET. The gene discussed is DNER; the disease is diffuse large B-cell lymphoma.